Trial intelligence / Profile preview

Asciminib Real-World Study in Newly Diagnosed CML-CP (China)

ChiCTR2600116168Phase 4Recruiting

Sponsor

Union Hospital

Start

Jan 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1